CEOs of Wells Fargo and Pfizer caution the U.S. could lose its edge to China without innovation
Albert Bourla, CEO of Pfizer, Charlie Scharf, Wells Fargo & Company CEO and Kathy Warden, Northrop Grumman Chair & CEO ...
Albert Bourla, CEO of Pfizer, Charlie Scharf, Wells Fargo & Company CEO and Kathy Warden, Northrop Grumman Chair & CEO ...
European healthcare stocks jumped on Wednesday, mirroring moves in the United States, propelled by a deal between Pfizer and President ...
Wall Street's three major indexes managed to close Tuesday's choppy session higher, marking quarterly and monthly gains, even as investors ...
Thomas Fuller | SOPA Images | Lightrocket | Getty ImagesPfizer on Monday said it would buy weight loss drugmaker Metsera ...
Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.Dado ...
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use ...
Workplace collaboration software maker Smartsheet will be taken private by buyout firms Vista Equity Partners and Blackstone in a deal ...
Pfizer's experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive ...
Moderna pushed back its break-even goal by two years on Thursday as it delayed the timeline for developing several key ...
COVID cases rise as new boosters are on the way - CBS News
© 2024 LSD News title="Jegtheme">Jegtheme.